Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19

Wenping Gong; Jianping Xie; Hao Li; Ashok Aspatwar

doi:10.3389/fimmu.2023.1147704

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19

Wenping Gong, Jianping Xie, Hao Li, Ashok Aspatwar

Research output: Contribution to journal › Editorial › Scientific

3 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Article number	1147704
Number of pages	3
Journal	Frontiers in Immunology
Volume	14
DOIs	https://doi.org/10.3389/fimmu.2023.1147704
Publication status	Published - 9 Feb 2023
Publication type	B1 Journal article

Funding

This study was funded by the Beijing Municipal Science & Technology Commission (Grant No. 7212103 and L192065), the National Natural Science Foundation of China (Grant No. 81801643, and No. 32070937), and the National key research and development program of China (grant number 2022YFA1303500-003), Finnish Cultural Foundation, and Tampere Tuberculosis Foundation (AA)

Keywords

immune response
mechanism
Mycobacterium tuberculosis
peptide
vaccine

ASJC Scopus subject areas

Immunology and Allergy
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fimmu.2023.1147704Licence: CC BY

fimmu-14-1147704-1Final published version, 285 KBLicence: CC BY

https://urn.fi/URN:NBN:fi:tuni-202303243125Licence: CC BY

Cite this

@article{91bba06566e340e194162dc728e99f80,

title = "Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19",

keywords = "immune response, mechanism, Mycobacterium tuberculosis, peptide, vaccine",

author = "Wenping Gong and Jianping Xie and Hao Li and Ashok Aspatwar",

note = "Funding Information: This study was funded by the Beijing Municipal Science & Technology Commission (Grant No. 7212103 and L192065), the National Natural Science Foundation of China (Grant No. 81801643, and No. 32070937), and the National key research and development program of China (grant number 2022YFA1303500-003), Finnish Cultural Foundation, and Tampere Tuberculosis Foundation (AA) ",

year = "2023",

month = feb,

day = "9",

doi = "10.3389/fimmu.2023.1147704",

language = "English",

volume = "14",

}

TY - JOUR

T1 - Editorial

T2 - Research advances of tuberculosis vaccine and its implication on COVID-19

AU - Gong, Wenping

AU - Xie, Jianping

AU - Li, Hao

AU - Aspatwar, Ashok

N1 - Funding Information: This study was funded by the Beijing Municipal Science & Technology Commission (Grant No. 7212103 and L192065), the National Natural Science Foundation of China (Grant No. 81801643, and No. 32070937), and the National key research and development program of China (grant number 2022YFA1303500-003), Finnish Cultural Foundation, and Tampere Tuberculosis Foundation (AA)

PY - 2023/2/9

Y1 - 2023/2/9

KW - immune response

KW - mechanism

KW - Mycobacterium tuberculosis

KW - peptide

KW - vaccine

U2 - 10.3389/fimmu.2023.1147704

DO - 10.3389/fimmu.2023.1147704

M3 - Editorial

C2 - 36845104

AN - SCOPUS:85148616982

SN - 1664-3224

VL - 14

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1147704

ER -